[1]范彩莲,徐传花.基于网络药理学的白术-菟丝子药对治疗多囊卵巢综合征的分子机制研究[J].医学信息,2024,37(02):47-54.[doi:10.3969/j.issn.1006-1959.2024.02.008]
 FAN Cai-lian,XU Chuan-hua.Molecular Mechanism of Baizhu-Tusizi Drugs in the Treatment of Polycystic Ovary Syndrome Based on Network Pharmacology[J].Journal of Medical Information,2024,37(02):47-54.[doi:10.3969/j.issn.1006-1959.2024.02.008]
点击复制

基于网络药理学的白术-菟丝子药对治疗多囊卵巢综合征的分子机制研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年02期
页码:
47-54
栏目:
中医药信息学
出版日期:
2024-01-15

文章信息/Info

Title:
Molecular Mechanism of Baizhu-Tusizi Drugs in the Treatment of Polycystic Ovary Syndrome Based on Network Pharmacology
文章编号:
1006-1959(2024)02-0047-08
作者:
范彩莲徐传花
(1.南京中医药大学研究生院,江苏 南京 210023;2.南京中医药大学附属医院常州市中医医院妇科,江苏 常州 213004)
Author(s):
FAN Cai-lianXU Chuan-hua
(1.Graduate School of Nanjing University of Chinese Medicine,Nanjing 210023,Jiangsu,China;2.Department of Gynecology,Changzhou Hospital of Traditional Chinese Medicine,Affiliated Hospital of Nanjing Universityof Chinese Medicine,Changzhou 213004,Jiangsu,China)
关键词:
白术菟丝子网络药理学多囊卵巢综合征靶点预测
Keywords:
BaizhuTusiziNetwork pharmacologyPolycystic ovary syndromeTargets prediction
分类号:
R285.6
DOI:
10.3969/j.issn.1006-1959.2024.02.008
文献标志码:
A
摘要:
目的 通过网络药理学方法,探讨中药白术-菟丝子在治疗多囊卵巢综合征(PCOS)中的作用机理,为开发新药和应用古典方剂提供依据。方法 利用医学药物信息与分析平台(TCMSP)的数据库获取白术、菟丝子的主要化学成份和作用靶标,利用ADME对白术、菟丝子进行有效成分的选择;通过Gencards、PharmGkb、DisGeNET、DRUGBANK等多个不同的数据库获取PCOS作用靶点,通过String平台对PCOS进行蛋白交互作用的研究,建立PPI网络结构,并对可能的蛋白结构进行深入的挖掘。利用Metascape技术对“药-成分-靶点”进行研究,并利用Cytoscape3.7.1软件建立“白术-菟丝子-PCOS-途径”。结果 筛选出白术-菟丝子药对有效活性成分15个,作用于198个预测靶点;筛选出疾病靶点2200个;韦恩图得到共同靶点136个;白术-菟丝子药对对PCOS的调节通路起着调节内分泌、卵巢功能等作用,其作用途径包括AGE-RAGE信号通路、IL-17信号通路、MAPK信号通路等。结论 白术-菟丝子在治疗PCOS中可能通过参与调节AGE-RAGE信号通路、IL-17信号通路、MAPK信号通路等作用于AKT1、JUN、CASP3、MAPK8等靶点调节内分泌及卵巢功能,为白术-菟丝子药对的临床开发利用提供基础。
Abstract:
Objective To study the mechanism of Chinese medicine Baizhu-Tusizi in the treatment of polycystic ovary syndrome(PCOS) based on network pharmacology, in order to provide a basis for the development of new drugs and the application of classical formulas.Methods The database of Traditional Chinese Medicine Systems Pharmacology Platform (TCMSP) was used to obtain the main chemical components and targets of Baizhu and Tusizi, and ADME was used to select the active ingredients of Baizhu and Tusizi; PCOS targets were obtained through Gencards, PharmGkb, DisGeNET, DRUGBANK and other different databases, and protein interaction was studied on PCOS through the String platform, PPI network structure was established, and possible protein structures were deeply explored. The "drug-ingredient-target" was studied using Metascape technology, and the "Baizhu-Tusizi-PCOS-pathway" was established using Cytoscape 3.7.1 software.Rseults A total of 15 active ingredients were screened for Baizhu-Tusizi drugs, which acted on 198 predicted targets; 2200 disease targets were screened; Wayne diagram obtained 136 common targets; Baizhu-Tusizi drugs played a regulatory role in regulating endocrine and ovarian function on the regulatory pathway of PCOS, including AGE-RAGE signaling pathway, IL-17 signaling pathway, MAPK signaling pathway, etc.Conclusion In the treatment of PCOS, Baizhu-Tusizi may regulate endocrine and ovarian function by participating in the regulation of AGE-RAGE signaling pathway, IL-17 signaling pathway, MAPK signaling pathway, etc. on AKT1, JUN, CASP3, MAPK8 and other targets, providing a basis for the clinical development and utilization of Baizhu-Tusizi drug pairs.

参考文献/References:

[1]Neves LPP,Marcondes RR,Maffazioli GN,et al.Nutritional and dietary aspects in polycystic ovary syndrome: insights into the biology of nutritional interventions[J].Gynecol Endocrinol,2020,36(12):1047-1050.[2]曹梦娣.补肾健脾法改善PCOS慢性低度炎症状态的疗效及其与肥胖相关性的研究[D].南京:南京中医药大学,2021.[3]Hopkins AL.Network pharmacology:The next paradigm in drug discovery[J].Nature Chemical Biology,2008,4(11):682-690.[4]韩聪,夏铭鸿,胡渊龙,等.基于网络药理学和分子对接分析续断-桑寄生改善多囊卵巢综合征作用的机制[J].山东科学,2022,35(3):7-16.[5]袁仁智,唐鹏,肖卫琼,等.当归-菟丝子干预肾虚血瘀型多囊卵巢综合征网络药理学作用机制[J].新中医,2020,52(3):83-88.[6]肖卫琼,袁仁智,康开彪.半夏-苍术-香附组药干预痰湿型多囊卵巢综合征的生物机制[J].中医药导报,2020,26(13):144-150.[7]侯阿美,储继军.基于数据挖掘的中医药治疗多囊卵巢综合征的用药规律分析[J].西南医科大学学报,2021,44(4):392-398.[8]Szklarczyk D,Gable AL,Lyon D,et al.STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets[J].Nucleic Acids Res,2019,47(D1):D607-D613.[9]Zhou Y,Zhou B,Pache L,et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J].Nat Commun,2019,10(1):1523.[10]郭灵娜.补肾化痰汤联合二甲双胍治疗多囊卵巢综合征临床观察[J].光明中医,2022,37(16):3003-3005.[11]刘畅.补肾健脾方对多囊卵巢综合征患者行体外受精-胚胎移植助孕后妊娠结局的影响[D].杭州:浙江中医药大学,2022.[12]李燕,陈素红,吉星,等.白术多糖对自发性2型糖尿病小鼠血糖及相关指标的影响[J].中国实验方剂学杂志,2015,21(10):162-165.[13]柯江维,王建红,赵宏.菟丝子黄酮对心理应激雌性大鼠海马-下丘脑-垂体-卵巢轴性激素受体的影响[J].中草药,2006,37(1):90-92.[14]Shah KN,Patel SS.Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome[J].Pharm Biol,2016,54(6):975-983.[15]Mihanfar A,Nouri M,Roshangar L,et al.Therapeutic potential of quercetin in an animal model of PCOS: Possible involvement of AMPK/SIRT-1 axis[J].Eur J Pharmacol,2021,900:174062.[16]Santos JMS,Monte APO,TLBGLins,et al.Kaempferol can be used as the single antioxidant in the in vitro culture medium, stimulating sheep secondary follicle development through the phosphatidylinositol 3-kinase signaling pathway[J].Theriogenology,2019.136:86-94.[17]Jiang H,Yamashita Y,Nakamura A,et al.Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes[J].Sci Rep,2019,9(1):2690.[18]Nekoonam S,Naji M,Nashtaei MS,et al.Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients[J].Arch GynecolObstet,2017,295(4):1041-1050.[19]Goto M,Iwase A,Ando H,et al.PTEN and Akt expression during growth of human ovarian follicles[J].J Assist Reprod Genet,2007,24(11):541-546.[20]Chen WS,Peng XD,Wang Y,et al.Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice[J].Mol Cell Biol,2009,29(11):3151-3162.[21]George S,Rochford JJ,Wolfrum C,et al.A family with severe insulin resistance and diabetes due to a mutation in AKT2[J].Science,2004,304(5675):1325-1328.[22]van Dijk TH,Laskewitz AJ,Grefhorst A,et al.A novel approach to monitor glucose metabolism using stable isotopically labelled glucose in longitudinal studies in mice[J].Lab Anim,2013,47(2):79-88.[23]Monden M,Koyama H,Otsuka Y,et al.Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2[J].Diabetes,2013,62(2):478-489.[24]Foroozanfard F,Soleimani A,Arbab E,et al.Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome[J].J Nephropathol,2017,6(1):15-24.[25]Xie Q,Xiong X,Xiao N,et al.Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice[J].Stem Cells Int,2019,2019:9782373.

更新日期/Last Update: 1900-01-01